(Q46529379)

English

Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning

scientific article published in August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

Langerhans cell histiocytosis specific to childhood

1 reference

based on heuristic

inferred from title

author name string

Steiner M

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

Matthes-Martin S

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

Attarbaschi A

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

Minkov M

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

Grois N

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

Unger E

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

Holter W

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

Vormoor J

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

Wawer A

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

Ouachee M

10

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

Woessmann W

11

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

Gadner H

12

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

language of work or name

0 references

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

36

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

215-225

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

The histiocytoses: the fall of the Tower of Babel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

A randomized trial of treatment for multisystem Langerhans' cell histiocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

Cyclosporine A therapy for multisystem langerhans cell histiocytosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

Allogeneic bone marrow transplantation in a patient with chemotherapy-resistant progressive histiocytosis X.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

Hematopoietic stem cell transplantation (HSCT) for Langerhans cell histiocytosis (LCH) in Japan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

Unrelated cord blood transplantation for an infant with chemotherapy-resistant progressive Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

Successful treatment of refractory Langerhans cell histiocytosis with unrelated cord blood transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

Current therapy for Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

The measurement of performance in childhood cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

An hypothesis Langerhans cell histiocytosis: the failure of the immune system to switch from an innate to an adaptive mode

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: Experience of the French Langerhans Cell Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

Anti-CD52 antibody, alemtuzumab, binds to Langerhans cells in Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

21 January 2018

Langerhans' cell histiocytosis--still an unsolved problem

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation for Langerhans' cell histiocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive Langerhans cell histiocytosis in an infant with Klinefelter syndrome successfully treated with allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated cord blood transplantation in an infant with severe multisystem Langerhans cell histiocytosis: clinical outcome, engraftment and culture of monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

7 January 2021

based on heuristic

inferred from DOI database lookup

Histiocytosis syndromes in children: II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Clinical Writing Group of the Histiocyte Society

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

7 January 2021

based on heuristic

inferred from DOI database lookup

Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment of Langerhans'-cell histiocytosis with etanercept

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705015

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705015

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15937510

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46529379&oldid=2207932148"